Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore innovative ways to price products for maximum profit. Implement these strategies to boost your revenue and attract customers.
23,980 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...
New Fed minutes show policymakers worry that persistent energy costs could keep inflation above the 2% goal, even as ...
When markets wobble, fear can block smart moves. This guide walks you through a calm, practical approach to a market ...
A rare ‘super’ niño looking could intensify weather extremes this year, impacting crops, energy costs, and budgets. H...
Inflation surging is reordering the playbook for investors as political pressure over rate cuts intensifies. This art...
A retirement stress test shows that while buying into Trump Tower is financially possible for some, sustaining the li...
When a top analyst starts coverage on GE Vernova, it can spark a notable move in the stock. This piece breaks down wh...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
Micron Technology has been a market darling, but a different S&P 500 stock has surged even more this year. This guide...